Clinical Trial Update: Vascular Effects of Hesperidin in Metabolic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the vascular effects of hesperidin in metabolic syndrome, with a focus on endothelial dysfunction. The current trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Metabolic Syndrome

Drugs mentioned

• Hesperidin (Hesperidin)

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Endothelial Dysfunction, Metabolic Syndrome | Phase 2 | Status: UNKNOWN